Trials
Search / Trial NCT06233253

Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Jan 22, 2024

Trial Information

Current as of March 08, 2025

Completed

Keywords

ClinConnect Summary

This clinical trial is studying how an online mindfulness program can help reduce anxiety for people preparing for their first screening colonoscopy. A colonoscopy is a procedure that checks for signs of colorectal cancer, and many patients feel anxious before the test. High levels of anxiety can lead to problems like difficulty with bowel preparation or even canceling the procedure. Mindfulness is a technique that helps people focus on the present moment, which can lower anxiety levels. By testing this online program, researchers hope to see if it can make patients feel calmer and more comfortable before their colonoscopy.

To participate in this study, you need to be between 45 and 75 years old and scheduled for your first screening colonoscopy at Ohio State University. You also should be at average risk for colorectal cancer and have access to the internet, a working phone, and email. If you are interested, you will be asked to complete mindfulness exercises online leading up to your procedure. The goal is to help you feel less anxious and more prepared. This trial is currently recruiting participants, so it could be a good opportunity to explore a new way to manage pre-procedural anxiety.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients must be ages 45-75
  • Patients must be at average risk for colorectal cancer (CRC)
  • Patients must have scheduled their first-time screening colonoscopy as an outpatient at Ohio State University (OSU) at least 14 days in advance
  • Patients must be able to speak and read English
  • Patients must have daily access to a working telephone, email address, and internet connection
  • Patients must provide consent
  • Exclusion Criteria:
  • Previous colonoscopy
  • Colonoscopy for diagnostic purposes
  • Auditory or visual impairment that prevents internet use
  • Previous cancer diagnosis (other than skin cancer)
  • Previous diagnosis of a mental health disorder
  • Current mental health treatment
  • Family history of CRC
  • Personal history of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
  • Confirmed or suspected hereditary CRC syndrome, such as familial adenomatous polyposis or Lynch syndrome

Trial Officials

Katz

Principal Investigator

Ohio State University Comprehensive Cancer Center

About Ohio State University Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.

Locations

Columbus, Ohio, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0